Zika Virus Detection Using RT-PCR Specific Primers
Find Innovative SolutionsGenerate Solutions
Solution Overview
Problem
Current methods for diagnosing Zika virus infection are time-consuming and face challenges in specificity, particularly in distinguishing it from other flaviviruses, necessitating a rapid and sensitive detection method.
Innovation Solution
The development of reagents and methods for PCR-based detection of Zika virus in bodily fluids, utilizing reverse transcription PCR (RT-PCR) and real-time PCR techniques, with specific primers and buffers to amplify and identify Zika virus RNA, enabling rapid and specific detection.
Engineering Contradictions & Design Principles
Engineering Contradiction Analysis
1Measurement precision
If virus isolation from blood samples is used for diagnosis, then detection accuracy is improved, but time consumption increases
Solution Approach 1:
The patent performs reverse transcription of viral RNA to cDNA before PCR amplification, preparing the target nucleic acid in advance for rapid detection. This preliminary conversion enables subsequent quick amplification and detection without time-consuming virus isolation steps
Solution Approach 2:
The patent replaces the mechanical virus isolation process with molecular biology techniques (RT-PCR). Instead of physically isolating viruses from blood samples through complex procedures, the method directly detects viral RNA through reverse transcription and amplification, dramatically reducing time while maintaining accuracy
2Productivity
If serology methods are used for diagnosis, then detection speed is improved, but specificity deteriorates due to cross-reactivity with other flaviviruses
Solution Approach 1:
The patent designs primers and probes that target specific regions of Zika virus RNA genome, creating localized specificity at the molecular level. The primers are engineered to bind only to unique Zika viral sequences, distinguishing it from other flaviviruses even though they share similar overall structures
Solution Approach 2:
The patent uses real-time PCR with specific temperature cycling parameters and fluorescence detection thresholds to enhance specificity. By optimizing annealing temperatures and using TaqMan probes with specific melting characteristics, the method achieves high specificity while maintaining rapid detection speed
Applied Scientific Principles
This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.
Function Achieved in This Case
Enables rapid and specific detection of Zika virus in small sample volumes, improving diagnostic efficiency and reducing cross-reactivity with other flaviviruses.
Implementation Method 1
generating multiple complementary DNA (cDNA) copies of at least portions of ZIKV RNA comprises using a reverse transcriptase to effect reverse transcription of said at least portions of ZIKV RNA
Implementation Method 2
generating multiple copies of said cDNA copies of ZIKV RNA by polymerase chain reaction (PCR) amplification
Data Source
AI summary
Applicant discloses herein kits for identifying the presence of Zika virus in a sample. In embodiments, these kits comprise reagents disclosed herein. Applicant further provides kits for use in detecting ZIKV in a sample, the kits comprising reagents disclosed herein. In embodiments, kits include primers directed to Zika virus (ZIKV) nucleic acid sequences, the primers capable of hybridizing to ZIKV nucleic acids and to copies of ZIKV nucleic acids (including to cDNA copies of ZIKV nucleic acids). Applicant discloses herein reagents for detecting Zika virus (ZIKV) in a sample, the reagents including one or more nucleic acid primers that are capable of hybridizing to a ZIKV nucleic acid (including to cDNA copies of ZIKV nucleic acids).